These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17147199)

  • 21. Asymmetric influences of pointing on saccade latency in hemi-Parkinson's disease.
    Ventre-Dominey J; Ford Dominey P; Broussolle E
    Neuropsychologia; 2001; 39(5):470-7. PubMed ID: 11254929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
    Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
    Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequences of memory-guided saccades in Parkinson's disease.
    Vermersch AI; Rivaud S; Vidailhet M; Bonnet AM; Gaymard B; Agid Y; Pierrot-Deseilligny C
    Ann Neurol; 1994 Apr; 35(4):487-90. PubMed ID: 8154878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memory-contingent saccades and the substantia nigra postulate for essential blepharospasm.
    Hotson JR; Boman DR
    Brain; 1991 Feb; 114 ( Pt 1A)():295-307. PubMed ID: 1998888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eye movement abnormalities in spinocerebellar ataxia type 17 (SCA17).
    Hübner J; Sprenger A; Klein C; Hagenah J; Rambold H; Zühlke C; Kömpf D; Rolfs A; Kimmig H; Helmchen C
    Neurology; 2007 Sep; 69(11):1160-8. PubMed ID: 17846415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Context-dependent effects of substantia nigra stimulation on eye movements.
    Basso MA; Liu P
    J Neurophysiol; 2007 Jun; 97(6):4129-42. PubMed ID: 17392414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eye movement quantitative evaluation before and after high-dose 6-methylprednisolone in multiple sclerosis.
    Versino M; Bergamaschi R; Callieco R; Romani A; Castelnovo G; Beltrami G; Cosi V
    Acta Neurol Scand; 1994 Feb; 89(2):105-10. PubMed ID: 8191872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Premotor inhibitory neurons carry signals related to saccade adaptation in the monkey.
    Kojima Y; Iwamoto Y; Robinson FR; Noto CT; Yoshida K
    J Neurophysiol; 2008 Jan; 99(1):220-30. PubMed ID: 17977929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saccades in adult Niemann-Pick disease type C reflect frontal, brainstem, and biochemical deficits.
    Abel LA; Walterfang M; Fietz M; Bowman EA; Velakoulis D
    Neurology; 2009 Mar; 72(12):1083-6. PubMed ID: 19307542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oculomotor findings in the stages "on" and "off" in Parkinson disease patients].
    Degl'Innocenti F; Ginanneschi A; Cipparrone L
    Riv Neurol; 1988; 58(5):210-5. PubMed ID: 3231990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Human fast negative EEG potentials before express saccades].
    Moiseeva VV; Slavutskaia MV; Shul'govskiĭ VV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2007; 57(1):23-32. PubMed ID: 17432315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
    Carlsson T; Carta M; Muñoz A; Mattsson B; Winkler C; Kirik D; Björklund A
    Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Horizontal saccade dynamics across the human life span.
    Irving EL; Steinbach MJ; Lillakas L; Babu RJ; Hutchings N
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2478-84. PubMed ID: 16723459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of dopamine agonists in Parkinson's disease: an update.
    Bonuccelli U; Pavese N
    Expert Rev Neurother; 2007 Oct; 7(10):1391-9. PubMed ID: 17939774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saccadic eye movements in Parkinson's disease: II. Remembered saccades--towards a unified hypothesis?
    Lueck CJ; Crawford TJ; Henderson L; Van Gisbergen JA; Duysens J; Kennard C
    Q J Exp Psychol A; 1992 Aug; 45(2):211-33. PubMed ID: 1410556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Saccade control and eye-hand coordination in optic ataxia.
    Gaveau V; Pélisson D; Blangero A; Urquizar C; Prablanc C; Vighetto A; Pisella L
    Neuropsychologia; 2008 Jan; 46(2):475-86. PubMed ID: 17963798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's disease.
    Asai H; Hirano M; Furiya Y; Udaka F; Morikawa M; Kanbayashi T; Shimizu T; Ueno S
    Clin Neurol Neurosurg; 2009 May; 111(4):341-4. PubMed ID: 19097685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saccadic eye movements in Parkinson's disease: I. Delayed saccades.
    Lueck CJ; Tanyeri S; Crawford TJ; Henderson L; Kennard C
    Q J Exp Psychol A; 1992 Aug; 45(2):193-210. PubMed ID: 1410555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New perspectives on the pathophysiology of Parkinson's disease as assessed by saccade performance: a clinical review.
    Terao Y; Fukuda H; Ugawa Y; Hikosaka O
    Clin Neurophysiol; 2013 Aug; 124(8):1491-506. PubMed ID: 23499161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D3 receptor agonists for protection and repair in Parkinson's disease.
    Joyce JN; Millan MJ
    Curr Opin Pharmacol; 2007 Feb; 7(1):100-5. PubMed ID: 17174156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.